Rinosinusitis crónica

Referencias

1 Fokkens WJ, Lund VJ, Mullo J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012;50:225-6.
2 Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA2LEN study. Allergy 2011;66:1216-23.
3 Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis—a GALEN study. Allergy 2009;64:520-33.
4 Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the “top 10” physical and mental health in 1999. J Occup Environ Med 2003;45:5-14.
5 Chan Y, Kuhn FA. An update on the classifications, diagnosis, and treatment of rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2009;17:204-8.
6 Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003;113:1199-205.
7 National Center for Health Statistics. Summary health statistics for US adults: national health interview survey 2005. Vital Health Stat 2006;10:1-153.
8 Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, et al. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 2005;60:233-7.
9 Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003;3:1-6.
10 Sasama J, Sherris DA, Shin S-H, Kephart GM, Kern EB, Ponikau JU. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005;13:2-8.
11 Ah-See KW, Evans AS. Sinusitis and its management. BMJ 2007;334:358-61.
12 Hadfield PJ, Rowe-Jones JM, Mackay IS. The prevalence of nasal polyps in adults with cystic fibrosis. Clin Otolaryngol Allied Sci 2000;25:19-22.
13 Kaliner M. Treatment of sinusitis in the next millennium. Allergy Asthma Proc 1998;19:181-4.
14 Krause H. Allergy and chronic rhinosinusitis. Otolaryngol Head Neck Surg 2003;128:14-6.
15 Szczeklik A, Niz EÊ, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16:432-6.
16 Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011;86:427-43.
17 Clifton NJ, Jones NS. Prevalence of facial pain in 108 consecutive patients with aranasal mucopurulent discharge at endoscopy. J Laryngol Otol 2007;121:345-8.
18 Fahy C, Jones NS. Nasal polyposis and facial pain. Clin Otolaryngol Allied Sci 2001;26:510-3.
19 Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 2004;24:9-160.
20 Bhattacharyya N, Lee LN. Evaluating the diagnosis of chronic rhinosinusitis based on clinical guidelines and endoscopy. Otolaryngol Head Neck Surg 2010;143:147-51.
21 Meltzer EO, Hamilos DL, Hadley J, Lanza DC, Marple BF, Nicklas R, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155-212.
22 Lim M, Lew-Gor S, Darby Y, Brookes N, Scadding G, Lund VJ. The relationship between subjective assessment instruments in chronic rhinosinusitis. Rhinology 2007;45:144-7.
23 Royal College of Radiologists. Making the best use of a department of clinical radiology guidelines for doctors. 5th ed. RCR, 2003.
24 Ede MN, Hobson J, Woolford T. Imaging in sinusitis. Br J Gen Pract 2006;56:141-2.
25 Lloyd G. CT of the paranasal sinuses: study of a control series in relation to endoscopic sinus surgery. J Laryngol Otol 1990;104:477-81.
26 Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag 2008;4:507-12.
27 Hopkins C, Browne J, Slack R, Lund V, Brown P. The Lund-MacKay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg 2007;137:555-61.
28 Mullol J, Lopez E, Roca-Ferrer J, Vaubert A, Pujols L, Fernandez-Morata J, et al. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy 1997;27:1432-41.
29 Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg 2008;139:137-42.
30 Aggarwal R, Cardozo A, Homer JJ. The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci 2004;29:201-5.
31 Cannady S, Batra P, Citardi M, Lanza D. Comparison of delivery of topical medications to the paranasal sinuses via “vertex-to-floor” position and atomiser spray after FESS.
Otolaryngol Head Neck Surg 2005;133:735-40.
32 Grobler A, Weitzel EK, Buele A, Jardeleza C, Cheong YC, Field J, et al. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 2008;118:2078-81.
33 Mygind N, Sorensen H, Pedersen C. The nasal mucosa during long-term treatment with beclomethasone diproprionate aerosol. A light- and scanning electron microscopic study of nasal polyps. Acta Otolaryngol 1978;85:437-43.
34 Klemi P, Virolainen E, Puhakka H. The effect of intranasal beclomethasone diproprionate on the nasal mucosa. Rhinology 1980;18:19-24.
35 Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007;3:CD006394.
36 Wallwork B, Coman W, Mackay-Sim A, Grieff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006;116:189-93.
37 Benninger M. Epistaxis and its relationship to handedness with use of intranasal steroid spray. Ear Nose Throat J 2008;87:463-5.
38 Kennedy D. Functional endoscopic sinus surgery. Technique. Arch Otolaryngol 1985;111:643-9.
39 Wormald P-J, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope 2004;114:2224-7.
40 Poetker DM, Mendolia-Loffredo S, Smith TL. Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol 2007;21:84-8.
41 Khalil H, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev 2006;3:CD004458.
42 Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231-6.
43 Kim J, Kountakis S. The prevalence of Samter’s triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007;86:396-9.
44 Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001;31:1385-91.
45 Suh JD, Cohen NA, Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010;18:27-31.
46 Foreman A, Boase S, Psaltis A, Wormald P-J. Role of bacterial and fungal biofilms in chronic rhinosinusitis. Curr Allergy Asthma Rep 2012;12:127-35.
47 Ahmed J, Pal S, Hopkins C, Jayaraj S. Functional endoscopic balloon dilation of sinus ostia for chronic rhinosinusitis. Cochrane Database Syst Rev 2011;7:CD008515.
BMJ 2012;345:e7054 doi: 10.1136/bmj.e7054 (Published 30 October 2012) Page 6 of 6